Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Thomas Jefferson University
With
National Cancer Institute (NCI)
PRIMARY OBJECTIVES:
I. To collect multiparametric ultrasound (mp-US) data on 70 patients within 30 days of their radical prostatectomy.
II. To correlate the imaging data with whole mount prostatectomy specimens in order to optimize mp-US with a machine learning approach.
OUTLINE:
Patients receive perflutren lipid microspheres intravenously (IV) over 5-6 minutes and undergo ultrasound over 30 minutes. Patients may receive up to 2 additional doses of perflutren lipid microspheres during ultrasound.
After completion of study, patients are followed up for 30 days.
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Subject must be scheduled for radical prostatectomy for treatment of prostate cancer
Subject must be able and willing to give written informed consent for a contrast enhanced ultrasound study of the prostate prior to prostatectomy
Subject must be a male at least 18 years of age when informed consent is obtained
You may not be if
Participant in a clinical trial involving an investigational drug within the past 30 days
Patients with known or suspected hypersensitivity to perflutren, PEG, or any other component of Definity
Previous treatment for prostate cancer, including hormone therapy
Clinically unstable, severely ill, or moribund as per treating physician
Clareo Health | Prostate Cancer Diagnosis by Multiparametric Ultrasound (Wholemount)
